DLL3 was expressed in 99/980 (10.1%) NET/TC/AC, with 37 (3.8%) showing a weak, 28 (2.9%) showing a moderate and 34 (3.5%) displaying a strong expression, while 881 (89.9%) neoplasms were completely DLL3 negative. The gene discussed is DLL3; the disease is neoplasm.